Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

WisdomTree Total Earnings Fund (EXT)

72.00
Delayed Data
As of 3:59pm ET
 -0.25 / -0.35%
Today’s Change
29.04
Today|||52-Week Range
76.20
+1.28%
Year-to-Date

Investment Objective

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Earnings Index. Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index is a fundamentally weighted index that is comprised of earnings-generating companies within the broad U.S. Stock Market. The fund is non-diversified.

No recent news for WisdomTree Total Earnings Fund.

Performance

1 month-0.32% 3 years+8.98%
3 months+7.39% 5 years+11.14%
1 year-2.68% Since inception+6.12%
Data through 05/26/2016

Quote Details

Previous close$72.25
Open day’s range71.90 – 72.49
Net asset value (NAV)72.41 (05/25/2016)
Daily volume23,651
Average volume (3 months)4,240
Data as of 3:59pm ET, 05/26/2016

Peer Comparisonvs. Large blend ETFs

 EXTCategory
Performance 5-yr return+11.14%+10.97%
Expense Gross exp ratio0.28%0.41%
Risk 5 year sharpe ratio0.840.87
Net assets$57.3M$4.7B
Average market cap$50.0B$94.7B
Average P/E15.318.4
Dividend / Share--0.28%

Competitors

VOO Vanguard 500 Index Fund ETF Class
IVV iShares Core S&P 500 ETF
SPY SPDR® S&P 500 ETF

Holdings

Top 5 Sectors
Portfolio weighting
Financial service 16.98%
Energy 11.54%
Industrial materials 11.21%
Healthcare 10.88%
Consumer goods 10.64%
Top 10 Holdings
Portfolio weighting
AAPL Apple3.98%
XOM Exxon Mobil2.32%
BRKB Berkshire Hathaway2.21%
JPM JPMorgan Chase2.14%
WFC Wells Fargo1.82%
WMT Wal-Mart1.55%
JNJ Johnson & Johnson1.48%
VZ Verizon1.42%
MSFT Microsoft1.34%
GILD Gilead Sciences1.33%

Partner Offers